← Back to All Stocks

Virax Biolabs Group Limited (VRAX) Analysis

Generated on: 2025-06-22 15:29:14 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 3,825,915 shares

Analysis Values

Current Price
$0.82
Predicted Price
$0.91
Expected Return
10.51%
Confidence Score
0.90
RSI (14)
26.72 (buy)
MACD
-0.06
Volume
32,000
Float Shares
3,825,915
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249

VRAX

Virax Biolabs Group Limited
10.51%
Price: $0.82
Confidence: 0.90
News
RSI Buy
Last updated: 2025-06-22 15:29:14

Technical Analysis

RSI: 26.72 (buy)
MACD: -0.06
Technical Analysis Graph

Risk Analysis

Volatility
218.7%
Max Drawdown
-87.59%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
Benzinga - 2025-03-31 18:57
H.C. Wainwright initiated coverage on Virax Biolabs Group Limited (NASDAQ:VRAX), a U.K.-based company focused on detecting immune responses and diagnosing viral diseases. Virax Biolabs is developing T cell-based test technologies to provide an immunology profiling platform. T-cell testing can be particularly effective in diagnosing and therapeutics for post-viral syndromes (such as Long COVID and other chronic conditions linked to immune dysregulation). Also Read: EXCLUSIVE: Virax Biolabs Says I

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.